Patrick Sexton wins the 2022 Gordon Hammes Lectureship Award
The annual award honours an individual whose scientific contributions have had a major impact on research across all of biological chemistry.
New finding: nitroxyl represents a promising therapeutic intervention for cardiovascular emergencies in type 2 diabetes
A new study led by Monash University researchers has, for the first time, shown that the chemical compound 'nitroxyl' may represent an effective and rapid intervention for cardiovascular emergencies in type 2 diabetes.
Moderna to build manufacturing facility at Monash
Monash University is delighted that Moderna will be joining other world-leading research and technology companies in the Monash Technology Precinct, under an agreement signed with the Victorian government.
Victoria’s first mRNA innovation hub backed by state government
A collaborative team of Melbourne researchers from Monash University and the University of Melbourne have received $5.4 million from the Victorian government to establish The Victorian mRNA Innovation Hub to develop next-generation mRNA vaccines and
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
Burnet Institute, in collaboration with MIPS has received Proof of Concept funding from BioCurate to develop next-generation HIV antivirals.
The “master regulator” of inflammation: Monash researchers publish review on promising emerging drug target to treat chronic inflammatory states
Monash researchers, in collaboration with Queen Mary University of London, have published a state-of-the-art review on an emerging druggable target called FPR2, a key receptor involved in the regulation of inflammation.
New development for hormone-free male contraceptive pill
A new study led by a team of Monash researchers working to develop a male contraceptive pill has identified that stinging nettle leaf extract has the potential to block a protein that controls the movement of sperm.
WEHI and Monash drug discovery team nominated as finalists in prestigious Eureka Prizes
In recognition of their pioneering research, a team of Melbourne scientists from WEHI and Monash University have been shortlisted as finalists in this year’s Australian Museum Eureka Prizes.
Biotech start-up receives funding for anti-inflammatory research
A new start-up company led by researchers at The Australian National University and Monash University has received funding to develop a method to block inflammation caused by a number of common diseases, including cardiovascular disease,